WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced that a settlement hearing will be held on November 30, 2021, at 11:00 a.m. ET, before the Honorable Lewis J. Liman at the U.S. District Court for the Southern District of New York, 500 Pearl Street, New York, NY 10007 in the matter of In re Aclaris Therapeutics, Inc. Derivative Litigation, Lead Case No. 1:19-cv-10641-LJL.
On August 18, 2021, Judge Liman granted preliminary approval of the proposed settlement of the Consolidated Derivative Action as set forth in the Stipulation and Agreement of Settlement dated July 29, 2021, approved the form and manner of the Notice of Pendency and Proposed Settlement of Stockholder Derivative Action, and scheduled the Settlement Hearing. The Proposed Settlement involves Aclaris implementing certain corporate governance reforms and for attorneys’ fees to be paid to plaintiffs’ counsel by Aclaris’ insurer. The Settlement Hearing is being held to determine, among other things, whether the terms of the Stipulation are fair, reasonable, and adequate. A copy of the Notice can be accessed on the “Investor Overview” page of the “Investors” section of Aclaris’ website, www.aclaristx.com.
Stockholders have the right to object to the Proposed Settlement. The deadline for the submission by stockholders of an objection to the Proposed Settlement is November 16, 2021, fourteen (14) calendar days prior to the Settlement Hearing. To object, the stockholder must follow the procedures outlined in the Notice.
The Company states that there can be no assurance that the Proposed Settlement will receive final approval from the Court.
Thanks for visiting! Looking for some Chester County pride? We got you covered! Shop our MyChesCo store and show your love for Chester County, Pennsylvania. We got shirts, hats, and more – all with a unique ChesCo flair. Plus, proceeds from each purchase helps support our mission of bringing reliable information and resources to the people of Chester County.